Advertisement

Topics

Companies Related to "Recombinant Virus Vectors Treatment Glycogen Storage Disease type" [Most Relevant Company Matches] RSS

05:45 EDT 25th June 2019 | BioPortfolio

Here are the most relevant search results for "Recombinant Virus Vectors Treatment Glycogen Storage Disease type" found in our extensive corporate database of over 50,000 company records.

Showing "Recombinant Virus Vectors Treatment Glycogen Storage Disease type" Companies 1–25 of 5,900+

Extremely Relevant

AGSD!

The Association for Glycogen Storage Disease(UK) was founded in 1986. The purpose of the association shall be to organise a volunary support group for all persons affected with some form of Glycogen Storage Disease (GSD) and their families. The Primary Purpose of the Association is to act as a family contact and support group for all persons affected by some form of GSD and their families. The S...


Oxyrane UK Limited

WHO WE ARE Oxyrane UK Limited is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the Company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium. WHAT WE DO Using a proprietary, gly...

Relevant

Avigen

Avigen is a leader in the development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited diseases. Avigen's proposed gene therapy products are designed for in vivo administration to achieve the production of therapeutic proteins within the body. Avigen has honed it's strategic focus on developing a broad-based proprietary gene delivery technology, A...


Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Company’s strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...

Transgene

TRANSGENE is a leading integrated gene therapy company, dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited diseases. The Company's proprietary technology platform consists of five vector families including three of viral origin - adenovirus, retrovirus, vaccinia virus - and two of non viral origin - cellula...

Market Vectors ETF Trust

Market Vectors exchange-traded products have been offered since 2006 and span many asset classes, including equities, fixed income (municipal and international bonds) and currency markets. The Market Vectors family totaled $21.8 billion in assets under management, making it the seventh largest ETP family in the U.S. and tenth largest worldwide as of June 3...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Genetic Vectors Incorporated

Genetic Vectors is a biotechnology company which intends to specialize in the development of diagnostic and quality control tools for the biopharmaceutical, food and beverage industries.

Tenaya Therapeutics

Tenaya Therapeutics is a privately-held biopharmaceutical company focused on developing potentially curative treatments for heart disease of various underlying causes. Headquartered in South San Francisco, Calif., Tenaya was founded in 2016 by world-leading scientists from the Gladstone Institute’s Cardiovascular Division and the University of Texas S...

Neotropix, Inc.

The company has signed two key licensing agreements with strong industry partners. These agreements allow Neotropix to use novel therapeutics to conduct research and development on major cancer indications.Neotropix is preparing to begin clinical trials in 2006, and is seeking FDA approval to grant its virus orphan drug status for the treatment of small cell lung cancers. This will be the first ap...

GENiSYSS LLC

Your DNA's chemical makeup changes and is associated with diseases including cancer, diabetes, heart disease, autism and a long list of others. By storing DNA together with the best memories of you and your family, you can create a time capsule with both medical and sentimental value. GENiSYSS patented DNA Vaults are thumb-drive sized devices you keep in y...

rEVO Biologics

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its proprietary rPRO Technology platform -- a scalable, transgenic, and cost-effective method of protein production-- rEVO Biologics is bringing safe and...

DiObex

DiObex, Inc., a clinical-stage company based in San Francisco, is developing unique, first-in-class therapies for the critically under-served metabolic disease market. Our pipeline products address the markets for the treatment of type 1 diabetes, type 2 diabetes and its co-morbidities such as hypertension, dyslipidemia and visceral adiposity (often referred to collectively as “metabolic syndrom...

Vindon Scientific

provide outsourced storage, managed facilities and storage collaborations to pharma and biopharma clients. With controlled environment storage suites in the UK, Ireland, Atlanta, USA - and from mid 2013, California – Vindon provide Stability Storage at a complete range of World Climatic ICH conditions as well as unique con...

Novirio Pharmaceutical Incorporated

Novirio Pharmaceuticals is an independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases. Building on our expertise in nucleoside chemistry and biology and other small molecule therapeutic compounds, we are positioned to become a leader in the antiviral pharmaceuticals market. Our efforts focus on sig...

GENOVO Incorporated

Gene therapy using viral vectors for the treatment of cancer, anemia, hepatitis and diabetes.

Prosidion Ltd

(OSI) Prosidion is the diabetes and obesity business group within OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) dedicated to the discovery and development of novel drugs for the treatment of type 2 diabetes and obesity. (OSI) Prosidion's lead compound PSN9301 is a Dipeptidyl Peptidase IV (DP-IV) inhibitor currently in Phase II clinical trials. PSN357, a glycogen phosphorylase inhibitor, is undergoing Ph...

PsiOxus Therapeutics, Ltd.

PsiOxus Therapeutics is a development stage biotechnology company using non-traditional approaches to develop novel therapeutics that address cancer and other clinically unmet diseases. The Company’s lead candidate is MT-102, a dual action Anabolic Catabolic Transforming Agent (ACTA) in phase II clinical development for the treatment of cachexia and ...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine antigen such as those used in currently marketed influenza, hepatitis B and human papilloma virus (HPV) blockbuster vaccines. Care Capital of Princeton is the lead investor in th...

Diabetes & Glandular Disease Clinic of San Antonio

The Diabetes & Glandular Disease Clinic, P.A. (DGD) offers the best in treatment for hormonal and metabolic disorders such as type 1 and 2 diabetes, gestational diabetes, thyroid disease, osteoporosis, lipid disorders (high cholesterol), pituitary/adrenal gland problems, menstrual disorders and hirsutism (excessive facial hair on women). All our doctors are board-certified in Endocrinology & Metab...

Caringo

Caringo is the global leader in object storage and developer of the Caringo Object Storage Platform powered by CAStor – software that enables massive scalability and future-proof accessibility of unstructured data. Caringo object storage enables cloud storage solutions, big data repositories and general storage infrastructure replacing NAS, tape and V...

GeneMax

GeneMax develops innovative immunotherapies in the fields of oncology and infectious disease. Our patented technology restores or increases antigen processing and antigen specific immune responses. GeneMax has demonstrated preclinical efficacy in animal models of lung cancer and melanoma as well as proof of principle for infectious disease pathogens.GeneMax’s program also includes developing a t...

Micro Design International

MDI is dedicated to simplifying storage management for networks. We have provided data storage solutions that are rich in function and value for over 25 years. Customers enjoy our simple yet elegant approach to accessing and managing information on a network We are a company dedicated to simplifying the management of network storage. We believe everyone should have the freedom to choose what is si...

vTv Therapeutics LLC

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of in...

MuscleSound

Based in Denver, Colorado, MuscleSound® patented methodology and software has made non-invasive, real-time measurement of muscle glycogen (energy) content levels a reality. Using standard ultrasound technology, MuscleSound® measures muscle glycogen content in seconds, while its software generates real-time reports based upon muscle-specific ultrasoun...


More From BioPortfolio on "Recombinant Virus Vectors Treatment Glycogen Storage Disease type"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks